Amid the rush for a SARS-CoV-2 vaccine to deal with the COVID-19 pandemic, a robust risk assessment must be conducted, and mitigation strategies applied.
Rajika Jindani
Advertisement
Rajika Jindani is a medical resident at University of Miami.
Articles by Rajika Jindani
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
2
Welcome to CPHI Frankfurt 2025
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
